Literature DB >> 11510255

Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis.

D Baszko-Blaszyk1, A E Grzegorzewska, W Horst-Sikorska, J Sowinski.   

Abstract

Chronic renal failure (CRF) causes deterioration of the fluid, electrolyte, and acid-base balances, azotemia, and impairment of the structure and function of many systems. In the skeletal system, CRF changes both the quality and quantity of the bone through its multifactorial influence on bone metabolism, leading to osteopenia, osteoporosis, and increased risk of fracture. The aim of the present study was to work up the quickest and most sensitive schedule for detecting osteoporosis in chronic renal insufficiency patients treated with CAPD. Thirty-seven uremic patients were included in the study. Bone mineral density was measured by dual-energy x-ray absorptiometry in lumbar spine, femoral neck, forearm (33% distal and ultradistal sites), and total body. Analyzing all five sites, we made the assessment that the prevalence of osteoporosis in our group of patients reached 48.6%. If only one site was evaluated, the ultradistal part of forearm yielded the highest frequency of diagnosis of osteoporosis (37.8%). Next came the femoral neck and total body (21.6% each). When the two sites in the forearm were taken into account together, the incidence of osteoporosis reached 40.5%. We conclude that the quickest and most sensitive method of detecting osteoporosis in CAPD patients is to measure bone mass in both forearm sites (33% distal and ultradistal), then in the femoral neck.

Entities:  

Mesh:

Year:  2001        PMID: 11510255

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  5 in total

1.  Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

Authors:  Fettah Fevzi Ersoy; Stauros Ploumis Passadakis; Paul Tam; Evaggelos Dimitros Memmos; Pericles Konstantinos Katopodis; Cetin Ozener; Fehmi Akçiçek; Taner Camsari; Kenan Ateş; Rezzan Ataman; John George Vlachojannis; Athanasios Nicholas Dombros; Cengiz Utaş; Tekin Akpolat; Semra Bozfakioğlu; George Wu; Ibrahim Karayaylali; Turgay Arinsoy; Panagiotis Charalampos Stathakis; Mahmut Yavuz; John Dimitrios Tsakiris; Chrysostomos Athanasios Dimitriades; Mehmet Emin Yilmaz; Meral Gültekin; Binnur Karayalçin; Mehmet Yardimsever; Dimitrios George Oreopoulos
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  FGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients.

Authors:  Vural Taner Yilmaz; Sebahat Ozdem; Levent Donmez; Ramazan Cetinkaya; Gultekin Suleymanlar; F Fevzi Ersoy
Journal:  Eurasian J Med       Date:  2015-06

Review 3.  Osteoporosis in the elderly with chronic kidney disease.

Authors:  F Fevzi Ersoy
Journal:  Int Urol Nephrol       Date:  2006-11-11       Impact factor: 2.266

4.  Can lumbar spine bone mineral density predict readmission in denosumab-treated patients with chronic kidney disease?

Authors:  Ben-Chung Cheng; Ying-Chou Chen
Journal:  J Investig Med       Date:  2016-08-31       Impact factor: 2.895

5.  Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.

Authors:  Guey-Shiun Huang; Tzong-Shinn Chu; Meei-Fang Lou; Shiow-Li Hwang; Rong-Sen Yang
Journal:  BMC Musculoskelet Disord       Date:  2009-06-04       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.